UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

JNCI : Journal of the National Cancer Institute, 2019-03, Vol.111 (3), p.245-255

2019

Volltextzugriff (PDF)

Interstitial flow and its effects in soft tissues

Annual review of biomedical engineering, 2007-01, Vol.9 (1), p.229-256

2007

Volltextzugriff (PDF)

Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling

Cancer cell, 2007-06, Vol.11 (6), p.526-538

2007

Volltextzugriff (PDF)

Consensus recommendations for improving the cancer clinical trial matching environment

Cancer, 2024-01, Vol.130 (1), p.11-15

Fleury, Mark E.

2024

Volltextzugriff (PDF)

Synergy between Interstitial Flow and VEGF Directs Capillary Morphogenesis in vitro through a Gradient Amplification Mechanism

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (44), p.15779-15784

2005

Volltextzugriff (PDF)

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

JNCI : Journal of the National Cancer Institute, 2021-03, Vol.113 (3), p.244-257

2021

Volltextzugriff (PDF)

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation

JAMA oncology, 2019-03, Vol.5 (3), p.326

2019

Volltextzugriff (PDF)

Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a survey

Cancer, 2024-01, Vol.130 (1), p.68-76

2024

Volltextzugriff (PDF)

National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data

Journal of clinical oncology, 2024-04

2024

Volltextzugriff (PDF)

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials

JAMA oncology, 2021-01, Vol.7 (1), p.131

2021

Volltextzugriff (PDF)

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology

Journal of clinical oncology, 2024-04, Vol.42 (10), p.1181-1192

2024

Volltextzugriff (PDF)

Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials

JAMA network open, 2022-07, Vol.5 (7), p.e2220053-e2220053

2022

Volltextzugriff (PDF)

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Clinical cancer research, 2021-05, Vol.27 (9), p.2424-2429

2021

Volltextzugriff (PDF)

Feasibility of institution‐agnostic, EHR‐integrated regional clinical trial matching

Cancer, 2024-01, Vol.130 (1), p.60-67

2024

Volltextzugriff (PDF)

A call to action to advance patient‐focused and decentralized clinical trials

Cancer, 2024-04, Vol.130 (8), p.1193-1203

2024

Volltextzugriff (PDF)

Autologous Morphogen Gradients by Subtle Interstitial Flow and Matrix Interactions

Biophysical journal, 2006-07, Vol.91 (1), p.113-121

2006

Volltextzugriff (PDF)

Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic Status-Reply

JAMA oncology, 2021-06, Vol.7 (6), p.940

2021

Volltextzugriff (PDF)

Reimbursing Patients for Participation in Cancer Clinical Trials

JAMA oncology, 2019-07, Vol.5 (7), p.932

2019

Volltextzugriff (PDF)

Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination

JAMA network open, 2021-12, Vol.4 (12), p.e2138219-e2138219

2021

Volltextzugriff (PDF)

Strategies to Advance Equity in Cancer Clinical Trials

American Society of Clinical Oncology educational book, 2022-04, Vol.42 (42), p.1-137

2022

Volltextzugriff (PDF)

Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop

The oncologist, 2014-01, Vol.19 (1), p.21-31

2014

Volltextzugriff (PDF)

Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence

JCO clinical cancer informatics, 2020, Vol.4 (4), p.35-49

2020

Volltextzugriff (PDF)

Reducing Tobacco-Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop

The oncologist (Dayton, Ohio), 2014-01, Vol.19 (1), p.21-31

2014

Volltextzugriff (PDF)

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

PloS one, 2009-03, Vol.4 (3), p.e4724-e4724

2009

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

Interstitial flow and its effects in soft tissues

Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling

Consensus recommendations for improving the cancer clinical trial matching environment

Synergy between Interstitial Flow and VEGF Directs Capillary Morphogenesis in vitro through a Gradient Amplification Mechanism

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation

Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a survey

National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology

Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Feasibility of institution‐agnostic, EHR‐integrated regional clinical trial matching

A call to action to advance patient‐focused and decentralized clinical trials

Autologous Morphogen Gradients by Subtle Interstitial Flow and Matrix Interactions

Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic Status-Reply

Reimbursing Patients for Participation in Cancer Clinical Trials

Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination

Strategies to Advance Equity in Cancer Clinical Trials

Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop

Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence

Reducing Tobacco-Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

Plant functional traits have globally consistent effects on competition

Suchergebnisse filtern